By analyzing the expression of Claudin18.2 and TFRC in the tissue RNA sequence of patients with different clinical cancers, the results of Fig. 1A showed that Claudin18 was mainly expressed in gastric and pancreatic cancers, but the expression was highest in gastric cancers. The gene discussed is TFRC; the disease is pancreatic neoplasm.